SEC 13F Intelligence

Foresite Capital Management IV, LLC / VYGR

Foresite Capital Management IV, LLC’s Voyager Therapeutics Inc Position

Does Foresite Capital Management IV, LLC own Voyager Therapeutics Inc (VYGR)? Not currently — the last reported position was 516.8K shares worth $6M in Q3 2020; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$6M
Q3 2020
Shares
516.8K
% of Portfolio
+1.24%
Quarters Held
7
position exited

Position History VYGR

Reported value by quarter
Q1 ’19: $3MQ1 ’19Q2 ’19: $15MQ2 ’19Q3 ’19: $14MQ3 ’19Q4 ’19: $12MQ4 ’19Q1 ’20: $5MQ1 ’20Q2 ’20: $7MQ2 ’20Q3 ’20: $6MQ3 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2020516.8K$6M+1.24%
Q2 2020516.8K$7M+3.18%
Q1 2020516.8K$5M+5.83%
Q4 2019830.6K$12M+5.00%
Q3 2019830.6K$14M+4.62%
Q2 2019536.8K$15M+4.13%
Q1 2019177.8K$3M+1.22%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Foresite Capital Management IV, LLC’s full portfolio or all institutional holders of VYGR.